Ruxolitinib in Severe, COVID-19 Patients: A Randomized Phase-II Trial
Evidence Based Medicine presented by InpharmD™ · InpharmD™
September 2, 20205m 53s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A prospective, multi-center, single-blind, randomized controlled phase II trial assessing the efficacy and safety of ruxolitinib in hospitalized COVID-19 patients